|
Volumn 490, Issue 7418, 2012, Pages 7-
|
Gene therapies need new development models
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALIPOGENE TIPARVOVEC;
DRUG DESIGN;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG LEGISLATION;
DRUG MANUFACTURE;
GENETIC MODEL;
HUMAN;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
VIRAL GENE THERAPY;
DRUG INDUSTRY;
DRUG MONITORING;
GENETIC THERAPY;
HUMANS;
RARE DISEASES;
RISK ASSESSMENT;
|
EID: 84867002985
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/490007a Document Type: Note |
Times cited : (12)
|
References (0)
|